Dianthus Therapeutics, Inc. /DE/ ($DNTH)
Filing Information
| Accession Number | 0001669866-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 14, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
368,754
Total Value
$10,839,931.23
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 12, 2026 | Exercise/Conversion | 122,918 | $6.70 | $823,550.60 | 122,918 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 12, 2026 | Sale | 43,505 | $80.69 | $3,510,418.45 | 79,413 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 12, 2026 | Sale | 65,517 | $81.74 | $5,355,359.58 | 13,896 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 12, 2026 | Sale | 12,796 | $82.60 | $1,056,949.60 | 1,100 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 12, 2026 | Sale | 200 | $83.38 | $16,676.00 | 900 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 12, 2026 | Sale | 900 | $85.53 | $76,977.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Mar 12, 2026 | Exercise/Conversion | 122,918 | $0.00 | $0.00 | 59,741 | Direct | โ | View Details |